Clinical trials
Observational Amyloid Neuropathies, Familial trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
93 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 8 |
| 2020 | 10 |
| 2021 | 9 |
| 2022 | 11 |
| 2023 | 13 |
| 2024 | 12 |
| 2025 | 9 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 37 |
| Unknown status | 22 |
| Completed | 18 |
| Not yet recruiting | 6 |
| Active, not recruiting | 3 |
| Enrolling by invitation | 3 |
| Terminated | 2 |
| Withdrawn | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University Hospital, Essen | 5 |
| Alnylam Pharmaceuticals | 3 |
| CENTOGENE GmbH Rostock | 3 |
| IRCCS Azienda Ospedaliero-Universitaria di Bologna | 3 |
| AstraZeneca | 2 |
| Insel Gruppe AG, University Hospital Bern | 2 |
| Istanbul University - Cerrahpasa | 2 |
| Mayo Clinic | 2 |
| Pfizer | 2 |
| Tianjin Medical University | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amyloid Neuropathies, Familial | 93 |
| Amyloidosis | 19 |
| Heart Failure | 13 |
| Cardiomyopathies | 12 |
| Cardiomyopathy, Hypertrophic | 8 |
| Aortic Valve Stenosis | 7 |
| Immunoglobulin Light-chain Amyloidosis | 7 |
| Amyloidosis, Familial | 6 |
| Polyneuropathies | 6 |
| Alzheimer Disease | 5 |
Trials
Showing 26 to 50 of 93. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.